Global Capsule Endoscopy Diagnostics Market size was valued at USD 277.3 million in 2018 to USD 467.0 million in 2024 and is anticipated to reach USD 829.0 million by 2032, at a CAGR of 7.37% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Capsule Endoscopy Diagnostics Market Size 2024
USD 467.0 Million
Capsule Endoscopy Diagnostics Market, CAGR
7.37%
Capsule Endoscopy Diagnostics Market Size 2032
USD 829.0 Million
The Global Capsule Endoscopy Diagnostics Market is driven by established players including Medtronic plc, Olympus Corporation, CapsoVision, IntroMedic Co., Ltd., Jinshan Science & Technology, Fujifilm Holdings Corporation, Check-Cap Ltd., RF System Lab, AnX Robotica Corp., and Chongqing Science & Technology Co. These companies maintain leadership through advanced product portfolios, global distribution networks, and continuous R&D investments in high-resolution imaging, AI-enabled diagnostics, and longer battery life. Among regions, North America led the market in 2024 with a 36.5% share, supported by strong healthcare infrastructure, favorable reimbursement frameworks, and early adoption of innovative diagnostic technologies.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Capsule Endoscopy Diagnostics Market grew from USD 277.3 million in 2018 to USD 467.0 million in 2024 and is projected to reach USD 829.0 million by 2032.
Capsule endoscopes led the product segment with a 62% share in 2024, driven by non-invasive design, patient comfort, and improved imaging capabilities.
Obscure gastrointestinal bleeding accounted for 45% of disease applications in 2024, supported by rising prevalence of undiagnosed bleeding and capsule endoscopy’s diagnostic effectiveness.
Hospitals dominated the end-user segment with a 52% share in 2024, reinforced by advanced infrastructure, skilled specialists, and high patient inflow for gastrointestinal diagnostics.
North America led globally with a 36.5% share in 2024, supported by healthcare infrastructure, reimbursement support, and strong adoption of innovative capsule technologies.
Market Segment Insights
By Product
Capsule endoscopes dominate the product segment, accounting for nearly 62% market share in 2024. Their strong adoption results from non-invasive nature, patient comfort, and high diagnostic accuracy. Advances in high-resolution imaging and extended battery life further support this leadership. Recorders, workstations, and software continue gaining traction, particularly with AI-powered features that enhance efficiency, streamline image analysis, and reduce diagnostic time, driving wider acceptance among healthcare providers.
For instance, Medtronic received FDA clearance for its PillCam Small Bowel 3 system, featuring improved imaging quality and adaptive frame rate technology to enhance diagnostic yield.
By Disease Type
Obscure gastrointestinal bleeding (OGIB) is the leading disease application, holding nearly 45% market share in 2024. Rising prevalence of undiagnosed intestinal bleeding cases drives strong reliance on capsule endoscopy. The method’s effectiveness in detecting small intestinal bleeding sources has boosted clinical adoption. Crohn’s disease and small bowel tumors are secondary growth drivers, with growing emphasis on early detection, patient monitoring, and improved outcomes supporting market expansion in these indications.
By End User
Hospitals lead the end-user segment, capturing nearly 52% market share in 2024. Their dominance is supported by advanced medical infrastructure, availability of skilled gastroenterologists, and ability to manage complex diagnostics. The growing patient volume for gastrointestinal disorders reinforces their leadership. Ambulatory surgical centers and diagnostic centers are expanding rapidly, driven by demand for convenient outpatient services, affordability, and accessibility. This shift highlights the increasing role of decentralized healthcare delivery models worldwide.
For instance, UnitedHealth Group highlighted that ambulatory surgery centers (ASCs) in the U.S. provide faster, safer, and more affordable care alternatives for gastrointestinal procedures compared to traditional hospitals.
Key Growth Drivers
Rising Prevalence of Gastrointestinal Disorders
The increasing global burden of gastrointestinal (GI) diseases is a primary driver for capsule endoscopy adoption. Disorders such as obscure gastrointestinal bleeding, Crohn’s disease, and celiac disease are rising due to lifestyle changes, aging populations, and dietary factors. Capsule endoscopy offers a non-invasive and highly accurate method for early diagnosis, improving patient outcomes and reducing treatment delays. Growing awareness and physician recommendations are strengthening demand across hospitals and diagnostic centers worldwide.
For instance, the Canadian Association of Gastroenterology highlighted capsule endoscopy’s effectiveness in diagnosing obscure GI bleeding and evaluating Crohn’s disease severity.
Technological Advancements in Capsule Design
Continuous innovation in capsule technology is boosting the market’s growth. Advanced capsules now feature higher-resolution cameras, longer battery life, improved image transmission, and even AI-enabled image analysis for enhanced diagnostic accuracy. These advancements reduce procedure times and improve detection rates for small bowel tumors and bleeding. Companies are focusing on R&D to expand capabilities such as multi-sensor integration and controlled navigation. Such improvements are making capsule endoscopy more efficient and widely accepted.
For instance, Olympus launched its EndoCapsule 10 system in Japan, offering upgraded image sensors and enhanced battery performance designed for prolonged small bowel examinations.
Preference for Minimally Invasive Diagnostics
Patients and healthcare providers increasingly prefer capsule endoscopy over traditional invasive procedures such as endoscopy and colonoscopy. The painless, sedation-free experience offers better comfort, shorter recovery times, and reduced hospital stays. This preference is supported by the growing emphasis on patient-centric care and outpatient diagnostic procedures. Insurance coverage and cost-effectiveness in developed markets also contribute to adoption. This shift toward non-invasive diagnostics is fueling steady demand, particularly in regions with strong healthcare infrastructure.
Key Trends & Opportunities
Integration of Artificial Intelligence (AI)
AI integration in capsule endoscopy is transforming diagnostic efficiency. AI-powered image analysis tools help physicians detect abnormalities faster and with greater accuracy, reducing human error and improving patient outcomes. Automated algorithms are being applied to conditions like Crohn’s disease and tumors, enabling early detection. This trend creates opportunities for technology providers to expand offerings. As AI becomes more accessible, demand for intelligent diagnostic platforms is expected to rise across developed and emerging healthcare markets.
For instance, AnX Robotica received FDA approval for its NaviCam ProScan, the first AI-assisted reading tool designed specifically for small bowel capsule endoscopy to detect suspected bleeding, marking a significant regulatory milestone in AI integration.
Expansion in Emerging Markets
Emerging economies present strong opportunities for market expansion, driven by rising healthcare investments, improving diagnostic infrastructure, and growing awareness about minimally invasive procedures. Countries in Asia Pacific, Latin America, and the Middle East are adopting capsule endoscopy at a rapid pace due to increasing gastrointestinal disease prevalence and a larger patient base. Partnerships between global players and local healthcare providers are further enhancing access, making these regions the fastest-growing markets for capsule endoscopy diagnostics.
For instance, Medtronic received approval from the U.S. Food and Drug Administration (FDA) for its PillCam Capsule Endoscopy system for at-home use. It has also received other FDA clearances and expanded indications for different PillCam products over time.
Key Challenges
High Cost of Procedures and Devices
The significant cost of capsule endoscopy devices and related diagnostic procedures remains a key challenge. Advanced capsules with high-resolution imaging and AI integration increase expenses, limiting affordability in low- and middle-income regions. Limited insurance coverage in many countries adds to patient burden, reducing adoption rates. For wider market penetration, manufacturers must focus on developing cost-effective solutions, while policymakers need to improve reimbursement frameworks to make this diagnostic tool more accessible globally.
Technical Limitations and Incomplete Diagnostics
Despite advancements, capsule endoscopy faces technical challenges that limit diagnostic outcomes. Issues such as incomplete transit through the gastrointestinal tract, image quality loss, and capsule retention reduce diagnostic reliability. In complex cases, physicians often require additional imaging or invasive procedures, which undermines its stand-alone value. Overcoming these limitations requires further R&D in navigation control, power efficiency, and multi-sensor capabilities. Addressing these gaps is essential for building trust and wider adoption among healthcare professionals.
Regulatory and Reimbursement Barriers
Strict regulatory requirements and inconsistent reimbursement policies hinder market growth. Obtaining approvals for innovative capsule technologies often involves long timelines, raising costs for manufacturers. Moreover, reimbursement frameworks vary widely across regions, with many healthcare systems offering limited or no coverage for capsule endoscopy. This lack of standardization affects adoption rates, particularly in emerging markets. Streamlined approval pathways and stronger insurance support are crucial to unlocking the full potential of capsule endoscopy diagnostics worldwide.
Regional Analysis
North America
North America led the market with revenues of USD 94.62 million in 2018, rising to USD 162.90 million in 2024, and projected to reach USD 297.60 million by 2032 at a CAGR of 7.8%. The region captured a 36.5% share in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, and a high prevalence of gastrointestinal disorders. Rapid adoption of capsule technologies and strong presence of key players reinforce its leadership. North America remains the largest and most established market globally, with continuous innovation driving long-term growth.
Europe
Europe generated USD 77.76 million in 2018, increasing to USD 129.98 million in 2024, and is projected to reach USD 228.47 million by 2032 at a CAGR of 7.2%. With a 29.2% share in 2024, Europe stands as the second-largest market. Strong adoption in Germany, the UK, and France, supported by robust healthcare systems and growing awareness of minimally invasive diagnostics, fuels regional expansion. Collaborative research programs and wider accessibility of capsule devices are expected to enhance Europe’s position, making it a stable and competitive market contributor.
Asia Pacific
Asia Pacific was valued at USD 63.73 million in 2018, expanding to USD 105.15 million in 2024, and forecasted to reach USD 181.55 million by 2032 at a CAGR of 7.0%. Holding a 23.6% share in 2024, the region benefits from large patient pools, increasing healthcare investments, and growing prevalence of gastrointestinal conditions. Rising adoption in China, India, and Japan, supported by improved infrastructure and awareness, underpins strong growth. Though penetration remains lower than developed regions, Asia Pacific demonstrates the fastest expansion in patient access, offering high long-term potential.
Latin America
Latin America recorded USD 21.88 million in 2018, rising to USD 35.97 million in 2024, and expected to reach USD 61.76 million by 2032 with a CAGR of 6.9%. The region represented 8.1% of the global market in 2024, with Brazil and Mexico leading adoption. Growth is supported by gradual improvements in healthcare infrastructure and increased awareness of non-invasive diagnostics. However, limited reimbursement and affordability challenges hinder faster uptake. With steady demand for improved gastrointestinal solutions, Latin America remains an emerging growth region with untapped opportunities.
Middle East
The Middle East market was valued at USD 12.04 million in 2018, increasing to USD 21.15 million in 2024, and forecasted to reach USD 39.63 million by 2032 at the fastest CAGR of 8.1%. Holding a 4.7% share in 2024, the region benefits from rising healthcare investments, especially across the GCC countries, and growing adoption of advanced diagnostics. Expanding medical facilities and government-backed healthcare initiatives are driving acceptance of capsule endoscopy. The Middle East demonstrates strong future growth potential and is emerging as a lucrative market for global players.
Africa
Africa generated USD 7.29 million in 2018, rising to USD 11.84 million in 2024, and projected to reach USD 19.98 million by 2032 at a CAGR of 6.7%. The region accounted for only 2.6% of the global market in 2024, constrained by limited infrastructure, high device costs, and low awareness. However, partnerships with global healthcare companies and ongoing modernization efforts are improving access to diagnostics. Rising gastrointestinal disease cases highlight unmet needs, making Africa a developing yet important market with opportunities for cost-effective capsule endoscopy solutions.
Market Segmentations:
By Product
Capsule Endoscopes
Recorders
Workstations
Software
By Disease Type
Obscure Gastrointestinal Bleeding (OGIB)
Crohn’s Disease
Small Bowel Tumors
Celiac Disease
Others
By End User
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The competitive landscape of the Global Capsule Endoscopy Diagnostics Market is characterized by the presence of established multinational corporations and specialized regional players, each striving to strengthen their market position through innovation and strategic initiatives. Leading companies such as Medtronic plc, Olympus Corporation, CapsoVision, IntroMedic, Jinshan Science & Technology, and Fujifilm Holdings Corporation dominate with extensive product portfolios, global distribution networks, and strong R&D capabilities. These players focus on advancing capsule technologies with features like high-resolution imaging, longer battery life, and AI-enabled diagnostic support to improve detection accuracy and efficiency. Emerging companies and regional manufacturers contribute by offering cost-effective solutions tailored to local market needs, expanding accessibility in developing economies. Strategic partnerships, mergers, and acquisitions remain critical strategies to expand product offerings and geographic presence. Competition continues to intensify as firms seek to balance technological sophistication with affordability, shaping a dynamic and rapidly evolving market environment.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In January 2025, CapsoVision received U.S. FDA clearance for its CapsoCam Plus capsule endoscopy device, now approved for pediatric patients aged two and older. This marks a significant expansion allowing non-invasive diagnostics for children.
In January 2024, AnX Robotica received FDA clearance for its NaviCam Small Bowel (SB) Video Capsule Endoscopy Systemwith expanded use for patients aged two and above, including tether-assisted esophagus visualization.
In December 2024, Medtronic announced the first successful patient ingestion of its new PillCam Genius SB Kit, offering simplified equipment management and remote procedure capabilities.
In May 2025, AnX Robotica unveiled NaviCam XS, NaviCam XST, and ESView 3.0at DDW, adding real-time esophageal view through a tethered capsule design.
Report Coverage
The research report offers an in-depth analysis based on Product, Disease Type, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Adoption of capsule endoscopy will increase due to growing demand for minimally invasive diagnostics.
AI integration will enhance accuracy and reduce physician workload in gastrointestinal diagnosis.
Hospitals will continue to lead adoption, supported by advanced infrastructure and skilled specialists.
Diagnostic centers will expand usage as outpatient demand for affordable procedures rises.
Technological innovations will deliver capsules with longer battery life and improved imaging.
Regional growth will accelerate in Asia Pacific and the Middle East with rising healthcare investments.
Cost-effective capsule models will drive penetration in low- and middle-income countries.
Collaborations between global players and local providers will expand access in emerging markets.
Regulatory improvements and broader reimbursement coverage will support higher adoption rates.
Competition will intensify as established firms and new entrants focus on product differentiation.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : CAPSULE ENDOSCOPY DIAGNOSTICS MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Regional Price Trend
3.6.2 Price Trend by product CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Application Categories
4.3 End User Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Application & End User Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Region
6.1.1. Global Capsule Endoscopy Diagnostics Market Import Volume By Region
6.2. Export Analysis by Region
6.2.1. Global Capsule Endoscopy Diagnostics Market Export Volume By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Capsule Endoscopy Diagnostics Market: Company Market Share
7.1. Global Capsule Endoscopy Diagnostics Market Company Volume Market Share
7.2. Global Capsule Endoscopy Diagnostics Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – BY APPLICATION SEGMENT ANALYSIS
8.1. Capsule Endoscopy Diagnostics Market Overview by Application Segment
8.1.1. Capsule Endoscopy Diagnostics Market Volume Share By Application
8.1.2. Capsule Endoscopy Diagnostics Market Revenue Share By Application
8.2. Polyps Detection
8.3. Crohn’s Disease Diagnosis
8.4. Ulcers Monitoring
8.5. Celiac Detection
8.6. Tumors Of Small Intestine
8.7. Occult Gastrointestinal Bleeding
8.8. Diverticulosis Detection CHAPTER NO. 9 : CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – BY END USER SEGMENT ANALYSIS
9.1. Capsule Endoscopy Diagnostics Market Overview by End User Segment
9.1.1. Capsule Endoscopy Diagnostics Market Volume Share By End User
9.1.2. Capsule Endoscopy Diagnostics Market Revenue Share By End User
9.2. Hospitals
9.3. Ambulatory Centers
9.4. Private Clinics CHAPTER NO. 10 : CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – REGIONAL ANALYSIS
10.1. Capsule Endoscopy Diagnostics Market Overview by Region Segment
10.1.1. Global Capsule Endoscopy Diagnostics Market Volume Share By Region
10.1.2. Global Capsule Endoscopy Diagnostics Market Revenue Share By Region
10.1.3. Regions
10.1.4. Global Capsule Endoscopy Diagnostics Market Volume By Region
10.1.5. Global Capsule Endoscopy Diagnostics Market Revenue By Region
10.1.6. Application
10.1.7. Global Capsule Endoscopy Diagnostics Market Volume By Application
10.1.8. Global Capsule Endoscopy Diagnostics Market Revenue By Application
10.1.9. End User
10.1.10. Global Capsule Endoscopy Diagnostics Market Volume By End User
10.1.11. Global Capsule Endoscopy Diagnostics Market Revenue By End User CHAPTER NO. 11 : NORTH AMERICA CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
11.1. North America Capsule Endoscopy Diagnostics Market Overview by Country Segment
11.1.1. North America Capsule Endoscopy Diagnostics Market Volume Share By Region
11.1.2. North America Capsule Endoscopy Diagnostics Market Revenue Share By Region
11.2. North America
11.2.1. North America Capsule Endoscopy Diagnostics Market Volume By Country
11.2.2. North America Capsule Endoscopy Diagnostics Market Revenue By Country
11.2.3. Application
11.2.4. North America Capsule Endoscopy Diagnostics Market Volume By Application
11.2.5. North America Capsule Endoscopy Diagnostics Market Revenue By Application
11.2.6. End User
11.2.7. North America Capsule Endoscopy Diagnostics Market Volume By End User
11.2.8. North America Capsule Endoscopy Diagnostics Market Revenue By End User
11.3. U.S.
11.4. Canada
11.5. Mexico CHAPTER NO. 12 : EUROPE CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
12.1. Europe Capsule Endoscopy Diagnostics Market Overview by Country Segment
12.1.1. Europe Capsule Endoscopy Diagnostics Market Volume Share By Region
12.1.2. Europe Capsule Endoscopy Diagnostics Market Revenue Share By Region
12.2. Europe
12.2.1. Europe Capsule Endoscopy Diagnostics Market Volume By Country
12.2.2. Europe Capsule Endoscopy Diagnostics Market Revenue By Country
12.2.3. Application
12.2.4. Europe Capsule Endoscopy Diagnostics Market Volume By Application
12.2.5. Europe Capsule Endoscopy Diagnostics Market Revenue By Application
12.2.6. End User
12.2.7. Europe Capsule Endoscopy Diagnostics Market Volume By End User
12.2.8. Europe Capsule Endoscopy Diagnostics Market Revenue By End User
12.3. UK
12.4. France
12.5. Germany
12.6. Italy
12.7. Spain
12.8. Russia
12.9. Rest of Europe CHAPTER NO. 13 : ASIA PACIFIC CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
13.1. Asia Pacific Capsule Endoscopy Diagnostics Market Overview by Country Segment
13.1.1. Asia Pacific Capsule Endoscopy Diagnostics Market Volume Share By Region
13.1.2. Asia Pacific Capsule Endoscopy Diagnostics Market Revenue Share By Region
13.2. Asia Pacific
13.2.1. Asia Pacific Capsule Endoscopy Diagnostics Market Volume By Country
13.2.2. Asia Pacific Capsule Endoscopy Diagnostics Market Revenue By Country
13.2.3. Application
13.2.4. Asia Pacific Capsule Endoscopy Diagnostics Market Volume By Application
13.2.5. Asia Pacific Capsule Endoscopy Diagnostics Market Revenue By Application
13.2.6. End User
13.2.7. Asia Pacific Capsule Endoscopy Diagnostics Market Volume By End User
13.2.8. Asia Pacific Capsule Endoscopy Diagnostics Market Revenue By End User
13.3. China
13.4. Japan
13.5. South Korea
13.6. India
13.7. Australia
13.8. Southeast Asia
13.9. Rest of Asia Pacific CHAPTER NO. 14 : LATIN AMERICA CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
14.1. Latin America Capsule Endoscopy Diagnostics Market Overview by Country Segment
14.1.1. Latin America Capsule Endoscopy Diagnostics Market Volume Share By Region
14.1.2. Latin America Capsule Endoscopy Diagnostics Market Revenue Share By Region
14.2. Latin America
14.2.1. Latin America Capsule Endoscopy Diagnostics Market Volume By Country
14.2.2. Latin America Capsule Endoscopy Diagnostics Market Revenue By Country
14.2.3. Application
14.2.4. Latin America Capsule Endoscopy Diagnostics Market Volume By Application
14.2.5. Latin America Capsule Endoscopy Diagnostics Market Revenue By Application
14.2.6. End User
14.2.7. Latin America Capsule Endoscopy Diagnostics Market Volume By End User
14.2.8. Latin America Capsule Endoscopy Diagnostics Market Revenue By End User
14.3. Brazil
14.4. Argentina
14.5. Rest of Latin America CHAPTER NO. 15 : MIDDLE EAST CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
15.1. Middle East Capsule Endoscopy Diagnostics Market Overview by Country Segment
15.1.1. Middle East Capsule Endoscopy Diagnostics Market Volume Share By Region
15.1.2. Middle East Capsule Endoscopy Diagnostics Market Revenue Share By Region
15.2. Middle East
15.2.1. Middle East Capsule Endoscopy Diagnostics Market Volume By Country
15.2.2. Middle East Capsule Endoscopy Diagnostics Market Revenue By Country
15.2.3. Application
15.2.4. Middle East Capsule Endoscopy Diagnostics Market Volume By Application
15.2.5. Middle East Capsule Endoscopy Diagnostics Market Revenue By Application
15.2.6. End User
15.2.7. Middle East Capsule Endoscopy Diagnostics Market Volume By End User
15.2.8. Middle East Capsule Endoscopy Diagnostics Market Revenue By End User
15.3. GCC Countries
15.4. Israel
15.5. Turkey
15.6. Rest of Middle East CHAPTER NO. 16 : AFRICA CAPSULE ENDOSCOPY DIAGNOSTICS MARKET – COUNTRY ANALYSIS
16.1. Africa Capsule Endoscopy Diagnostics Market Overview by Country Segment
16.1.1. Africa Capsule Endoscopy Diagnostics Market Volume Share By Region
16.1.2. Africa Capsule Endoscopy Diagnostics Market Revenue Share By Region
16.2. Africa
16.2.1. Africa Capsule Endoscopy Diagnostics Market Volume By Country
16.2.2. Africa Capsule Endoscopy Diagnostics Market Revenue By Country
16.2.3. Application
16.2.4. Africa Capsule Endoscopy Diagnostics Market Volume By Application
16.2.5. Africa Capsule Endoscopy Diagnostics Market Revenue By Application
16.2.6. End User
16.2.7. Africa Capsule Endoscopy Diagnostics Market Volume By End User
16.2.8. Africa Capsule Endoscopy Diagnostics Market Revenue By End User
16.3. South Africa
16.4. Egypt
16.5. Rest of Africa CHAPTER NO. 17 : COMPANY PROFILES
17.1. Olympus Corporation
17.1.1. Company Overview
17.1.2. Product Portfolio
17.1.3. Financial Overview
17.1.4. Recent Developments
17.1.5. Growth Strategy
17.1.6. SWOT Analysis
17.2. CapsoVision
17.3. Shangxian Minimal Invasive Inc.
17.4. Medtronic plc
17.5. INTROMEDIC
17.6. AnX Robotics
17.7. RF Co., Ltd.
17.8. BioCam
17.9. Other Key Players
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Global Capsule Endoscopy Diagnostics Market, and what is its projected size in 2032?
The market size was USD 467.0 million in 2024 and is projected to reach USD 829.0 million by 2032, reflecting steady worldwide demand growth.
At what Compound Annual Growth Rate is the Global Capsule Endoscopy Diagnostics Market projected to grow between 2025 and 2032?
The Global Capsule Endoscopy Diagnostics Market is forecasted to expand at a CAGR of 7.37% during 2025–2032, driven by technology advancements and increasing gastrointestinal disorder prevalence.
Which Global Capsule Endoscopy Diagnostics Market segment held the largest share in 2024?
Capsule endoscopes held the largest segment share at 62% in 2024, supported by strong adoption, patient comfort, improved imaging capabilities, and non-invasive diagnostic benefits worldwide.
What are the primary factors fueling the growth of the Global Capsule Endoscopy Diagnostics Market?
Growth is fueled by rising gastrointestinal disorder prevalence, continuous capsule technology advancements, and a global shift toward minimally invasive diagnostics enhancing accuracy and patient-friendly outcomes.
Who are the leading companies in the Global Capsule Endoscopy Diagnostics Market?
Key players include Medtronic, Olympus Corporation, CapsoVision, IntroMedic, Jinshan Science & Technology, Fujifilm Holdings Corporation, Check-Cap, RF System Lab, AnX Robotica, and Chongqing Science & Technology.
Which region commanded the largest share of the Global Capsule Endoscopy Diagnostics Market in 2024?
North America commanded the largest share at 36.5% in 2024, supported by advanced healthcare infrastructure, reimbursement policies, and high gastrointestinal disorder prevalence rates.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Global Mammography Systems Market size was valued at USD 1,746.1 million in 2018 to USD 2,649.7million in 2024 and is anticipated to reach USD 4,649.3 million by 2032, at a CAGR of 7.31% during the forecast period.Mammography Systems Market is Projected to Reach US$ 3.83 Bn in 2025: Increasing Demand From Medical Devices Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Mammography Systems Markets Are Going well and which are not? And Leading Players
Global Intragastric Balloons Market size was valued at USD 34.0 million in 2018 to USD 72.1 million in 2024 and is anticipated to reach USD 198.7 million by 2032, at a CAGR of 13.58% during the forecast period.Intragastric Balloons Market Was Valued at US$ 120 Mn in 2015, and is Expected To Reach US$ 248 Mn by 2025, Expanding At a CAGR of 7.6% from 2017 to 2025
Global Intravenous Access Devices Market size was valued at USD 4,593.5 million in 2018 to USD 6,547.0 million in 2024 and is anticipated to reach USD 10,658.4 million by 2032, at a CAGR of 6.31% during the forecast period.
The Global Digital Health Monitoring Devices Market size was valued at USD 1,979.16 million in 2018 to USD 3,794.87 million in 2024 and is anticipated to reach USD 11,844.47 million by 2032, at a CAGR of 14.25% during the forecast period.
Global Circular Staplers Market size was valued at USD 626.2 million in 2018 to USD 1,064.3 million in 2024 and is anticipated to reach USD 2,209.7million by 2032, at a CAGR of 9.62% during the forecast period.
Global Balloon Dilators Market size was valued at USD 1,544.2 million in 2018 to USD 2,221.7million in 2024 and is anticipated to reach USD 3,898.4 million by 2032, at a CAGR of 7.31 % during the forecast period.
The Mobile Gamma Cameras Market size was valued at USD 58.7 million in 2024 and is anticipated to reach USD 70.5 million by 2032, at a CAGR of 3.19% during the forecast period (2024-2032).
High Tibial Osteotomy HTO Plates Market size was valued at USD 227.8 million in 2024 and is anticipated to reach USD 310.76 million by 2032, at a CAGR of 4% during the forecast period.
Guillain Barre Syndrome Diagnostics Market size was valued at USD 139.53 million in 2024 and is anticipated to reach USD 173.03 million by 2032, at a CAGR of 2.8% during the forecast period.
The market for Inferior Vena Cava (IVC) filters is projected to grow from USD 878.72 million in 2024 to USD 1,765.16 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.49%.
The Handheld X-Rays Market was valued at USD 1,680.5 million in 2024 and is projected to reach USD 3,610.2 million by 2032, expanding at a CAGR of 10.03% during the forecast period.
The gamma knife market size was valued at USD 458.22 million in 2024 and is anticipated to reach USD 686.38 million by 2032, at a CAGR of 5.2 % during the forecast period (2024-2032).
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
